top of page

Novel, immune agonistic CEACAM1/5 antibody (YB-200) demonstrates anti-tumor efficacy ...

Updated: Apr 3, 2023

Authors: Katrin Rupalla, Michel Janicot, Alexej Schmidt, Iris Helfrich, Bernhard B. Singer

Full Title: Novel, immune agonistic CEACAM1/5 antibody (YB-200) demonstrates anti-tumor efficacy, and significantly increases tumor-associated B-cell population in syngeneic liver Hepa1-6 tumor microenvironment


This poster was presented at the SITC 2022.


SITC poster_final
.pdf
Download PDF • 2.43MB

Comentarios


bottom of page